Growth Metrics

Incyte (INCY) FCF Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 10,029.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 723.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -1,409.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 6,066.00
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn 4,275.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4,275.00
Dec 31, 2025 -391.00
Sep 30, 2025 832.00
Jun 30, 2025 -1,408.00
Mar 31, 2025 -230.00
Dec 31, 2024 521.00
Sep 30, 2024 -34.00
Jun 30, 2024 -6,649.00
Mar 31, 2024 -577.00
Dec 31, 2023 -96.00
Sep 30, 2023 -1,148.00
Jun 30, 2023 -1,136.00
Mar 31, 2023 11,259.00
Dec 31, 2022 740.00
Sep 30, 2022 -1,945.00
Jun 30, 2022 -226.00
Mar 31, 2022 -32.00
Dec 31, 2021 368.00
Sep 30, 2021 -1,134.00
Jun 30, 2021 717.00
Mar 31, 2021 2,841.00
Dec 31, 2020 5,500.00
Sep 30, 2020 507.00
Jun 30, 2020 1,627.00
Mar 31, 2020 -7,645.00
Dec 31, 2019 125.00
Sep 30, 2019 -1,326.00
Jun 30, 2019 4,619.00
Mar 31, 2019 -731.00
Dec 31, 2018 -352.00
Sep 30, 2018 4,177.00
Jun 30, 2018 -272.00
Mar 31, 2018 727.00
Dec 31, 2017 -7,788.00
Sep 30, 2017 1,836.00
Jun 30, 2017 4,979.00
Mar 31, 2017 -1,240.00
Dec 31, 2016 5,727.00
Sep 30, 2016 8,030.00
Jun 30, 2016 -3,365.00
Mar 31, 2016 136.00
Dec 31, 2015 4,720.00
Sep 30, 2015 4,254.00
Jun 30, 2015 -205.00
Mar 31, 2015 14,663.00
Dec 31, 2014 17,635.00
Sep 30, 2014 29,319.00
Jun 30, 2014 16,587.00
Mar 31, 2014 10,177.00
Dec 31, 2013 -5,832.00
Sep 30, 2013 16,277.00
Jun 30, 2013 1,415.00
Mar 31, 2013 -55,945.00